• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryCongress

This rare bipartisan agreement on over-the-counter hearing aids sounds like progress

By
Blake Cadwell
Blake Cadwell
Down Arrow Button Icon
By
Blake Cadwell
Blake Cadwell
Down Arrow Button Icon
August 18, 2022, 6:59 AM ET
Fewer than 25% of people with hearing loss seek care due to the stigma associated with hearing aids, high costs, and lack of access.
Fewer than 25% of people with hearing loss seek care due to the stigma associated with hearing aids, high costs, and lack of access.Getty Images

Listen carefully and you’ll hear something very strange. It’s the unfamiliar sound of political agreement.

Senators Elizabeth Warren (D-MA) and Chuck Grassley (R-IA) put down their sparring gloves in order to co-author the Over-The-Counter Hearing Aid Act several years ago. Donald Trump and Joe Biden have both supported it. Now the FDA finally released the final guidelines.

On Aug. 16, 2022, we witnessed a rare example of truly bipartisan legislation when the FDA issued a final rule enabling millions of Americans with perceived mild-to-moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist. The widely supported FDA guidelines are important for those with hearing loss, and a heartening piece of business and political news for those who don’t.

So, what does this mean for consumers who need hearing aids? The new guidelines make it easier and cheaper for everyday Americans to secure hearing aids. More people stand to benefit than you might think: One in ten Americans, or 37 million people, suffer from hearing loss that is severe enough to impact their daily life.

This 10% of the population–which includes me, a 32-year-old with hereditary hearing loss–is in a better position than most to appreciate just how important hearing is. We are probably among those least surprised to learn that hearing correlates with physical health, career success, and happiness in relationships.

Take it from me: It can be hard to admit you need hearing aids, no matter how you get them. I knew from a young age that I had mid-frequency hearing loss. For years, I adapted mostly by lip-reading, until the mask-wearing, and ubiquitous Zoom meetings of the pandemic forced me to bite the bullet.

Many of us also understand that hearing loss does not only affect the elderly. Thanks in large part to the increasing use of loud headphones, it is predicted that approximately one in five of today’s teens will experience some form of hearing loss. That is about 30% more than 20 years ago.

Equally disturbing is that fewer than 25% of those with hearing loss do anything about it. The stigma associated with hearing aids is one reason for this, but so are high costs and lack of access, particularly for rural Americans and housebound older folks.

A win for consumers

Studies show that people with hearing loss often wait 10 years before they get the aids they need. The FDA regulations for over-the-counter hearing aids will allow millions of Americans with perceived mild-to-moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription, or a fitting adjustment by an audiologist.

As new OTC entrants come to market, we expect consumer choices to increase exponentially—and costs to go down noticeably. Given that the average pair of hearing aids will set you back $4,800 and that most insurance plans don’t cover them, this is huge.

What we have here is an all-too-rare bright spot in the depressing reality of consumer health costs. Even for those who can afford hearing aids, the OTC options will be a boon. They will cut down on required doctor visits and the long drives and waiting times these often entail.

As hearing aids become more accessible–and more invisible–the stigma associated with using them should evaporate.

While the arrival of OTC hearing aids is an overall win, it will also raise concerns about quality. Established manufacturers and some audiology groups oppose turning hearing aids into a consumer product.

Current market leaders warn that if hearing aids aren’t carefully customized for the wearer, the hard-of-hearing risk paying for products that simply don’t work. It’s the sort of frustrating experience that might make the hard-of-hearing less likely to seek help again.

Given their reservations, expect existing hearing aid manufacturers to push hard for clear labeling and marketing guidelines that set their established products apart from OTC upstarts.

It’s great that lawmakers have stopped lobbing insults at each other to make progress on this issue. Maybe, if the 37 million Americans with hearing loss declare their approval loudly enough, we’ll be treated to the sweet sounds of political cooperation more often.

Blake Cadwell is the founder and CEO of Soundly, a hearing healthcare marketplace that helps consumers find products, compare prices, and find licensed audiologists. Inspired by Blake’s own confusing search for hearing aids, Soundly aims to modernize access to the hearing health industry.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not reflect the opinions and beliefs of Fortune.

More must-read commentary published by Fortune:

  • Here are the steps the airline industry is taking to create a better air travel experience for everyone
  • Howard Schultz once spoke of the ‘reservoir of trust’ he had with Starbucks employees–but his war on unions risks destroying that bond
  • Why India could single-handedly shape the future of e-commerce this summer
  • Here’s how the pandemic-fueled surge in gaming is reshaping our understanding of its effects on mental health
  • Stop calling them ‘job creators’

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Blake Cadwell
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

tired
CommentaryProductivity
AI can double output. Human biology can’t
By Scott HutchesonMarch 10, 2026
3 hours ago
sharma
CommentaryRisk
The AI risk that few organizations are governing
By Raj SharmaMarch 10, 2026
3 hours ago
trump
CommentaryOil
Something will cause inflation to go up this year, but it’s not oil
By Steve H. Hanke and John GreenwoodMarch 9, 2026
16 hours ago
Commentaryphilanthropy
Asia’s family offices and corporations must step up to replace a cash-strapped UN and fill the SDG funding gap
By Naina Subberwal BatraMarch 8, 2026
2 days ago
herrick
CommentaryWealth
I’ve been advising wealthy family offices on real estate for decades. This market requires another look at your 100-year plan
By Belinda G. SchwartzMarch 7, 2026
3 days ago
adams
CommentaryVaccines
Trump’s former Surgeon General: voters widely support vaccine access and want Washington to focus elsewhere
By Jerome AdamsMarch 7, 2026
3 days ago

Most Popular

placeholder alt text
Real Estate
Billionaires Elon Musk and Mark Zuckerberg used mortgages to buy multimillion-dollar mansions. Here’s why that’s a savvy financial decision
By Sydney LakeMarch 9, 2026
21 hours ago
placeholder alt text
Energy
Trump promised to fill America’s oil reserves ‘right to the top.’ A year later, oil has exceeded $100 and they’re still less than 60% full
By Tristan BoveMarch 9, 2026
20 hours ago
placeholder alt text
Personal Finance
Current price of silver as of Monday, March 9, 2026
By Joseph HostetlerMarch 9, 2026
1 day ago
placeholder alt text
Energy
Oil over $100, markets in free fall, and Iran's new supreme leader is Trump's 'worst case' scenario
By Jim EdwardsMarch 9, 2026
1 day ago
placeholder alt text
Middle East
Like Trump, Iran’s new supreme leader is a real estate mogul, with a house on ‘Billionaires’ Row,’ a villa in Dubai, and upscale European hotels
By Jason MaMarch 9, 2026
19 hours ago
placeholder alt text
Investing
Oracle is under pressure from more than $100 billion in debt and massive layoffs as it pushes ahead with Larry Ellison's 3-step transformation 
By Amanda GerutMarch 9, 2026
13 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.